15 Rue Traversiere
Paris 75012
France
33 1 89 20 62 00
https://www.euroapi.com/en
Settore/i:
Settore:
Impiegati a tempo pieno: 3.450
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Karl Rotthier | CEO & Director | 789,24k | N/D | 1968 |
Mr. Antoine Delcour | Chief Financial Officer | N/D | N/D | N/D |
Mr. Eric Berger | Chief Operating Officer | N/D | N/D | N/D |
Mr. Kai Rossen | Chief Scientific Officer | N/D | N/D | N/D |
Mr. Guillaume Rosso | Head of Investor Relations | N/D | N/D | N/D |
Mr. James DeYonker | Chief Legal, Compliance & IP Officer | N/D | N/D | N/D |
Mr. Bruno Laforge | Chief HR & Corp. Affairs Officer | N/D | N/D | N/D |
Ms. Cecile Maupas | Chief CDMO (Contract Devel. and Manufacturing Organization) Officer | N/D | N/D | N/D |
Mr. Laurent Alexandre | Chief Commercial Officer | N/D | N/D | N/D |
Mr. Vincent Touraille | Chief Strategy and M&A Officer | N/D | N/D | 1963 |
Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the composition of drugs for human and veterinary use. It provides contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids & hormones; and Opiates and controlled substances. The company was incorporated in 2021 and is headquartered in Paris, France.
L'ISS Governance QualityScore di Euroapi S.A. al 1 ottobre 2023 è 2. I criteri di valutazione fondamentali sono revisione: 8; Consiglio di Amministrazione: 2; diritti degli azionisti: 5; retribuzione: 4.